Literature DB >> 20962587

Reduced spermatogonial proliferation and decreased fertility in mice overexpressing cyclin E in spermatogonia.

Vasco Liberal1, Maria P De Miguel, Martha Henze, Manuel Nistal, Steven I Reed.   

Abstract

Cyclin E is a key component of the cell cycle regulatory machinery, contributing to the activation of Cdk2 and the control of cell cycle progression at several stages. Cyclin E expression is tightly regulated, by periodic transcription and ubiquitin-mediated degradation. Overexpression of cyclin E has been associated with tumor development and poor prognosis in several tumor types, including germ cell tumors and both cyclin E and its partner Cdk2 are required for normal spermatogenesis. Here we have generated and characterized transgenic mice overexpressing a cyclin E mutant protein, resistant to ubiquitin-mediated proteolysis, in testicular germ cells, under the control of the human EF-1alpha promoter. The transgenic mice develop normally and live a normal life span, with no signs of testicular tumor development. The transgenic mice display however reduced fertility and testicular atrophy, due to reduced spermatogonial proliferation as a consequence of deregulated cyclin E levels. Overall our results show that deregulation of cyclin E expression contribute to infertility, due to inability of the spermatogonial cells to start the mitotic cycles prior to entering meiosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20962587      PMCID: PMC3055205          DOI: 10.4161/cc.9.20.13544

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  34 in total

1.  Oogenesis in the mouse. A study of the meiotic prophase.

Authors:  K BORUM
Journal:  Exp Cell Res       Date:  1961-09       Impact factor: 3.905

2.  Deregulated cyclin E promotes p53 loss of heterozygosity and tumorigenesis in the mouse mammary gland.

Authors:  A P L Smith; M Henze; J A Lee; K G Osborn; J M Keck; D Tedesco; D M Bortner; M P Rosenberg; S I Reed
Journal:  Oncogene       Date:  2006-06-05       Impact factor: 9.867

Review 3.  The tao of stem cells in the germline.

Authors:  H Lin
Journal:  Annu Rev Genet       Date:  1997       Impact factor: 16.830

4.  Deregulated cyclin E induces chromosome instability.

Authors:  C H Spruck; K A Won; S I Reed
Journal:  Nature       Date:  1999-09-16       Impact factor: 49.962

Review 5.  Testicular germ-cell tumours in a broader perspective.

Authors:  J Wolter Oosterhuis; Leendert H J Looijenga
Journal:  Nat Rev Cancer       Date:  2005-03       Impact factor: 60.716

6.  Prognostic value of cyclin E and p53 expression in gastric carcinoma.

Authors:  T Sakaguchi; A Watanabe; H Sawada; Y Yamada; J Yamashita; M Matsuda; M Nakajima; T Miwa; T Hirao; H Nakano
Journal:  Cancer       Date:  1998-04-01       Impact factor: 6.860

Review 7.  Cyclin e overexpression reduces infiltrative growth in breast cancer: yet another link between proliferation control and tumor invasion.

Authors:  Pontus Berglund; Göran Landberg
Journal:  Cell Cycle       Date:  2006-03-15       Impact factor: 4.534

8.  Dynamic regulation of mitotic arrest in fetal male germ cells.

Authors:  Patrick S Western; Denise C Miles; Jocelyn A van den Bergen; Matt Burton; Andrew H Sinclair
Journal:  Stem Cells       Date:  2007-11-15       Impact factor: 6.277

9.  Phosphorylation of Mcm2 by Cdc7 promotes pre-replication complex assembly during cell-cycle re-entry.

Authors:  Li-Chiou Chuang; Leonardo K Teixeira; James A Wohlschlegel; Martha Henze; John R Yates; Juan Méndez; Steven I Reed
Journal:  Mol Cell       Date:  2009-07-31       Impact factor: 17.970

10.  Cyclin E overexpression impairs progression through mitosis by inhibiting APC(Cdh1).

Authors:  Jamie M Keck; Matthew K Summers; Donato Tedesco; Susanna Ekholm-Reed; Li-Chiou Chuang; Peter K Jackson; Steven I Reed
Journal:  J Cell Biol       Date:  2007-07-30       Impact factor: 10.539

View more
  1 in total

1.  Research highlights on a notable retrovirus and a popular guardian gene.

Authors:  Paraskevi Vogiatzi; Philip J Mason
Journal:  Cell Cycle       Date:  2010-12-15       Impact factor: 4.534

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.